GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Cyclically Adjusted PB Ratio

JW Pharmaceutical (XKRX:001060) Cyclically Adjusted PB Ratio : 2.65 (As of Jun. 05, 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Cyclically Adjusted PB Ratio?

As of today (2024-06-05), JW Pharmaceutical's current share price is ₩29600.00. JW Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩11,158.40. JW Pharmaceutical's Cyclically Adjusted PB Ratio for today is 2.65.

The historical rank and industry rank for JW Pharmaceutical's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:001060' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.53   Med: 2.62   Max: 4.02
Current: 2.57

During the past years, JW Pharmaceutical's highest Cyclically Adjusted PB Ratio was 4.02. The lowest was 1.53. And the median was 2.62.

XKRX:001060's Cyclically Adjusted PB Ratio is ranked worse than
60% of 730 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs XKRX:001060: 2.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

JW Pharmaceutical's adjusted book value per share data for the three months ended in Mar. 2024 was ₩11,689.190. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩11,158.40 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


JW Pharmaceutical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for JW Pharmaceutical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Cyclically Adjusted PB Ratio Chart

JW Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.35 3.01 2.04 1.65 3.18

JW Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 2.05 3.34 3.18 2.92

Competitive Comparison of JW Pharmaceutical's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Pharmaceutical's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's Cyclically Adjusted PB Ratio falls into.



JW Pharmaceutical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

JW Pharmaceutical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=29600.00/11158.4
=2.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, JW Pharmaceutical's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11689.19/118.8477*118.8477
=11,689.190

Current CPI (Mar. 2024) = 118.8477.

JW Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201406 9,850.144 99.353 11,782.905
201409 9,873.587 99.608 11,780.711
201412 10,225.794 99.098 12,263.740
201503 9,852.577 99.720 11,742.440
201506 9,906.501 100.050 11,767.765
201509 9,950.999 100.110 11,813.539
201512 10,223.294 100.220 12,123.478
201603 9,843.429 100.560 11,633.541
201606 9,139.724 100.790 10,777.212
201609 10,814.646 101.460 12,668.005
201612 11,063.507 101.560 12,946.754
201703 10,700.263 102.850 12,364.625
201706 10,665.310 102.610 12,353.061
201709 10,858.456 103.490 12,469.828
201712 10,849.549 102.990 12,520.089
201803 10,710.299 104.100 12,227.612
201806 11,168.842 104.130 12,747.442
201809 11,309.065 105.650 12,721.783
201812 10,486.405 104.350 11,943.317
201903 10,192.754 104.490 11,593.314
201906 10,254.206 104.880 11,619.840
201909 10,302.732 105.200 11,639.316
201912 9,515.265 105.120 10,757.871
202003 8,823.702 105.540 9,936.296
202006 8,498.208 104.870 9,630.900
202009 8,646.351 106.200 9,676.073
202012 9,018.421 105.765 10,133.925
202103 8,626.578 107.357 9,549.885
202106 8,473.825 107.579 9,361.477
202109 8,715.978 108.759 9,524.472
202112 8,740.698 109.676 9,471.608
202203 8,583.265 111.806 9,123.867
202206 8,650.892 114.083 9,012.214
202209 9,047.808 114.831 9,364.269
202212 10,036.350 115.200 10,354.124
202303 10,377.017 116.550 10,581.629
202306 10,986.715 117.140 11,146.892
202309 10,217.428 119.111 10,194.825
202312 11,327.599 118.848 11,327.599
202403 11,689.190 118.848 11,689.190

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


JW Pharmaceutical  (XKRX:001060) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


JW Pharmaceutical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Pharmaceutical (XKRX:001060) Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines